Skip header and navigation

Refine By

35 records – page 1 of 4.

[25th anniversary of the Swedish Pediatric Leukemia Group. Quite a number of children with acute lymphatic leukemia are cured]

https://arctichealth.org/en/permalink/ahliterature23933
Source
Lakartidningen. 1993 Sep 1;90(35):2883-6
Publication Type
Article
Date
Sep-1-1993
Author
G. Gustafsson
L. Wranne
Author Affiliation
Barnmedicinska kliniken, Ostersunds sjukhus.
Source
Lakartidningen. 1993 Sep 1;90(35):2883-6
Date
Sep-1-1993
Language
Swedish
Publication Type
Article
Keywords
Child
History, 20th Century
Humans
Leukemia, Lymphocytic, Acute - drug therapy - history - mortality
Medical Oncology - history - standards
Prognosis
Registries
Societies, Medical - history
Sweden
PubMed ID
8377562 View in PubMed
Less detail

[A Norwegian cancer researcher honoured by a memorial]

https://arctichealth.org/en/permalink/ahliterature18008
Source
Tidsskr Nor Laegeforen. 2003 Dec 23;123(24):3591
Publication Type
Article
Date
Dec-23-2003
Author
Ole Didrik Laerum
Author Affiliation
Gades Institutt, Avdeling for patologi, Universitetet i Bergen, Haukeland Universitetssykehus, Bergen.
Source
Tidsskr Nor Laegeforen. 2003 Dec 23;123(24):3591
Date
Dec-23-2003
Language
Norwegian
Publication Type
Article
Keywords
History, 19th Century
History, 20th Century
Humans
Male
Medical Oncology - history
Neoplasms - history
Norway
Portraits
Research - history
Sculpture
PubMed ID
14691512 View in PubMed
Less detail

[Cancer control studies at the N.N. Petrov Research Institute of Oncology].

https://arctichealth.org/en/permalink/ahliterature159316
Source
Vopr Onkol. 2007;53(3):355-65
Publication Type
Article
Date
2007

[Contribution of the Moscow P.A. Gertsen Research Institute of Oncology to the development of oncological immunology in the USSR].

https://arctichealth.org/en/permalink/ahliterature249155
Source
Vopr Onkol. 1978;24(11):10-6
Publication Type
Article
Date
1978
Author
V V Gorodinova
Source
Vopr Onkol. 1978;24(11):10-6
Date
1978
Language
Russian
Publication Type
Article
Keywords
Academies and Institutes - history
Allergy and Immunology - history
History, 20th Century
Humans
Medical Oncology - history
Moscow
Neoplasms - immunology
Abstract
The main steps in the development of experimental and clinical oncoimmunology in Moscow Research Institute of Oncology named after P.A. Herzen for the period of 75 years of its existence are reported.
PubMed ID
369130 View in PubMed
Less detail

Danish Breast Cancer Cooperative Group--DBCG: History, organization, and status of scientific achievements at 30-year anniversary.

https://arctichealth.org/en/permalink/ahliterature93219
Source
Acta Oncol. 2008;47(4):497-505
Publication Type
Article
Date
2008
Author
Blichert-Toft Mogens
Christiansen Peer
Mouridsen Henning T
Author Affiliation
The Danish Breast Cancer Cooperative Group, DBCG Secretariat, Rigshospitalet, Copenhagen.
Source
Acta Oncol. 2008;47(4):497-505
Date
2008
Language
English
Publication Type
Article
Keywords
Anniversaries and Special Events
Breast Neoplasms - history - therapy
Denmark
Female
History, 20th Century
History, 21st Century
Humans
Medical Oncology - history - organization & administration
Societies, Medical - history - organization & administration
Abstract
DBCG (Danish Breast Cancer Cooperative Group) constitutes a multidisciplinary organization established in 1975 by the Danish Surgical Society. The purpose involves first and foremost a nation-wide standardization of breast cancer treatment based on novel therapeutic principles, collaboration between experts handling diagnostic work-up, surgery, radiotherapy, medical oncology, and basic research, and, further, complete registration of relevant clinical data in a national data base attached to DBCG. Data are processed by the Secretariat personnel composed of statisticians, data managers, and data secretaries making current analyses of outcome results feasible. DBCG is run by the Executive Committee consisting of expert members appointed by their respective society. From 1978 the DBCG project gained widely accession from participating units, and since then nearly all newly diagnosed breast cancer incident cases are reported and registered in the national data base. Today, the data base includes approximately 80 000 incidents of primary breast cancer. Annually, the Secretariat receives roughly 1.5 million parameters to be entered into the data base. Over time DBCG has generated seven treatment programmes including in situ lesions and primary invasive breast cancer. Probands are subdivided into risk groups based on a given risk pattern and allocated to various treatment programmes accordingly. The scientific initiatives are conducted in the form of register- and cohort analysis or randomized trials in national or international protocolized settings. Yearly, about 4 000 new incident cases of primary invasive breast cancer and about 200 in situ lesions enter the national programmes. Further, about 600 women with hereditary disposition of breast cancer are registered and evaluated on a risk scale. The main achievements resulted in a reduction of relative risk of death amounting up to 20% and increased 5-year overall survival ascending from 60% to roughly 80%. This article is partly based on a Danish paper to be published in the Centenary Jubilee book of the Danish Surgical Society, 2008.
PubMed ID
18465316 View in PubMed
Less detail

The development of gynecological oncology in Scandinavia during the last 50 years.

https://arctichealth.org/en/permalink/ahliterature241240
Source
Acta Obstet Gynecol Scand Suppl. 1984;120:27-34
Publication Type
Article
Date
1984
Author
O. Kjellgren
Source
Acta Obstet Gynecol Scand Suppl. 1984;120:27-34
Date
1984
Language
English
Publication Type
Article
Keywords
Female
Genital Neoplasms, Female - immunology - pathology - radiotherapy - surgery
Gynecology - history
History, 20th Century
Humans
Medical Oncology - history
Ovarian Neoplasms - pathology
Radiotherapy Dosage
Radium - therapeutic use
Scandinavia
Uterine Cervical Neoplasms - pathology
Abstract
The last 50 years of development in gynecological oncology has changed the methods for the diagnosis of cancer and for treatment of cancer, both to give better treatment results. From the beginning the gynecologist could only inspect or palpate. Later on roentgen examination was introduced and later still microscopic diagnosis, more advanced diagnostic methods, e.g. endoscopy, ultrasound, isotope examination and advanced microscopic diagnosis and computerized tomography. Today we are waiting for the break-through in computerized tomography using nuclear spin resonance for the study of tumors and the spread of tumors. Parallel with the development in diagnosis, treatment has developed. Originally surgery was the only method available. Later on low energy radiation, endocrine therapy, chemotherapy and then high voltage energy treatment became available along with some experimental therapies. Today we have a broad range of therapeutic tools to use. In the future we might use prophylaxis more than we do today to prevent cancer and when cancer is present we might enhance the immune defense or introduce specific immuno-therapy with clonal antibodies, specially made for the actual tumor, and surgery, radiotherapy and chemotherapy will be used less.
PubMed ID
6380199 View in PubMed
Less detail

[Development of radiation treatment of tumors and of nuclear medicine in the P.A. Herzen Moscow Scientific Research Institute. On the 75th anniversary of the Institute].

https://arctichealth.org/en/permalink/ahliterature248223
Source
Radiobiol Radiother (Berl). 1978 Oct;19(5):535-9
Publication Type
Article
Date
Oct-1978

[Evolution and revolutionary events in oncology in the end of XX - beginning of XXI century].

https://arctichealth.org/en/permalink/ahliterature123303
Source
Vestn Ross Akad Med Nauk. 2012;(3):32-6
Publication Type
Article
Date
2012
Author
A M Garin
Source
Vestn Ross Akad Med Nauk. 2012;(3):32-6
Date
2012
Language
Russian
Publication Type
Article
Keywords
Antineoplastic Agents - history - therapeutic use
Drug Therapy - history - methods
History, 20th Century
History, 21st Century
Humans
Medical Oncology - history
Mutation
Neoplasms - genetics - history - therapy
Russia
Stem Cells - pathology
Abstract
This review highlights major achievements of the Russian oncology in the past decades, such as works of N.N. Petrov, L.A. Zilber, N.N. Blokhin, E.E. Pogosyants. Revolutionary shift in the understanding of the malignization process have become possible after decoding of human genome, as well as genome of several tumors such as breast cancer, acute myeloblastic leukemia, several brain tumors, testicular cancer and other neoplasms. The issue of stem cells being possible ancestors of tumor cells is also discussed in the review. Also the author observes main modern therapeutic approaches towards cancer treatment. It is specially highlighted that XXI century molecular biology achievements made it possible to start personal tumor treatment based on its' specific genotype.
PubMed ID
22712272 View in PubMed
Less detail

35 records – page 1 of 4.